Drugs / Test Product U
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04926246 | Jul 2021 → Feb 2022 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Test Product U | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04926246 ↗ |
| Known as | T10 | “T10: Test Product U” NCT04926246 ↗ |